drugset / Trial / NCT01810432
Study of Food on Evacetrapib (LY2484595) in Healthy Participants
RandomizedCrossoverOpen-labelBasic science
Summary
The purpose of this study is to measure how much of the drug gets into the blood stream and how long it takes the body to get rid of it when given to healthy participants. Information about any side effects that may occur will also be collected. The study has 2 periods. In each period, participants will take the study drug for 10 days, either with or without a meal. There is a minimum 14-day washout between each period. This study is approximately 50 days, not including screening. Screening is required within 28 days prior to the start of the study.
Timeline
- Start
- 2013-03
- Primary completion
- 2013-06
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Evacetrapib | Small molecule | 130 mg | Oral |
Indications
No indication recorded.